Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00309933 · ClinicalTrials.gov registry record
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- 2,697
- Enrollment target
NCT00309933: Completed study, sponsored by Eastern Cooperative Oncology Group.
NCT00309933 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 2,697 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00309933 has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- 2,697 participants
- Enrollment target
Study Summary
RATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast cancer survivors. PURPOSE: This clinical trial is studying quality of life in female breast cancer survivors and their spouse, partner, or acquaintance.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE cognitive assessment
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,697 participants |
| Start Date | 2006-04-03 |
| Est. Completion | 2011-03 |
What the finished NCT00309933 record still lists
NCT00309933 is an observational study that tracks outcomes without assigning an intervention. Its 2,697 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT00309933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00309933 about?
NCT00309933 is a clinical study titled "Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance". RATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast cancer survivors. PURPOSE: This clinical trial is studying quality of life in female breast cancer survivors and their ...
What is the current status of trial NCT00309933?
This trial is currently completed. The enrollment target is 2,697 participants. The study started on 2006-04-03. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00309933?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), cognitive assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00309933?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI